Testing effectiveness (Phase 2)Study completedNCT00489008What this trial is testingSRS Study in Patients With Non-Small Cell Lung CancerWho this might be right forLung Cancer M.D. Anderson Cancer Center 141
Large-scale testing (Phase 3)UnknownNCT02802540What this trial is testingNabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer PatientsWho this might be right forNon-Small Cell Lung CancerAnorexiaCachexia+1 more Instituto Nacional de Cancerologia de Mexico 78
Not applicableStudy completedNCT03116633What this trial is testingConcordance of Inivata Liquid Biopsy With Standard Tissue BiopsyWho this might be right forNon-Small Cell Lung Cancer Inivata 34
Testing effectiveness (Phase 2)Study completedNCT00234052What this trial is testingCarboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Northwestern University 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06323148What this trial is testingAdjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)Who this might be right forLung CancerEGFR Gene MutationMinimal Residual Disease Fudan University 226
Large-scale testing (Phase 3)Study completedNCT02477826What this trial is testingAn Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 2,747
Testing effectiveness (Phase 2)Looking for participantsNCT05777278What this trial is testingSavolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET OverexpressionWho this might be right forNon-small Cell Lung Cancer The First Affiliated Hospital of Guangzhou Medical University 29
Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Testing effectiveness (Phase 2)Ended earlyNCT00040768What this trial is testingBortezomib in Treating Patients With Advanced Non-small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01283516What this trial is testingA Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma KinaseWho this might be right forTumors Characterized by Genetic Abnormalities of ALK Novartis Pharmaceuticals 304
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552What this trial is testingEvaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Study completedNCT01900652What this trial is testingEmibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsWho this might be right forCarcinoma, Non-Small-Cell Lung Eli Lilly and Company 111
Not applicableStudy completedNCT01279408What this trial is testingObserving Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)Who this might be right forNon-small Cell Lung Carcinoma University Health Network, Toronto 46
Testing effectiveness (Phase 2)Study completedNCT00416650What this trial is testingErlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer Vanderbilt-Ingram Cancer Center 16
Large-scale testing (Phase 3)Looking for participantsNCT05085028What this trial is testingA Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer, Nonsmall Cell Imperial College London 1,750
Post-approval studies (Phase 4)UnknownNCT02778893What this trial is testingConmana Combined With Thalidomide to Treat NSCLCWho this might be right forNSCLC Henan Provincial People's Hospital 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06456138What this trial is testingTrametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLCWho this might be right forKRAS Mutation-Related TumorsAdvanced Lung CancerRefractory Tumor Shanghai Chest Hospital 60
Large-scale testing (Phase 3)Study completedNCT05807893What this trial is testingStudy to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain MetastasesWho this might be right forNon-small Cell Lung Cancer Stage IIBevacizumabImmunotherapy+1 more Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT01410214What this trial is testingErlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR MutationsWho this might be right forNon-small Cell Lung Cancer Stage IIIA Chinese Lung Cancer Surgical Group 80
Testing effectiveness (Phase 2)Study completedNCT00698815What this trial is testingPemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7 National Cancer Institute (NCI) 130